NMDA Receptor Modulation for Hyperarousal in PTSD

NCT03166501 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Depression
Post Traumatic Stress Disorder

Interventions

DRUG: Lanicemine
DRUG: Placebo

Sponsor

Baylor College of Medicine

Collaborators

[object Object]